2023
DOI: 10.1007/978-3-031-07392-2_67
|View full text |Cite
|
Sign up to set email alerts
|

Per- and Polyfluoroalkyl Substances (PFAS) and Their Toxicology as Evidenced Through Disease and Biomarkers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 67 publications
0
1
0
Order By: Relevance
“…Over the last decade, increasing attention has been given to understand the detrimental impacts of per- and polyfluoroalkyl substances (PFAS) on the environment and on human and animal health. PFAS are prevalent in natural settings, and, paired with their extreme stability against various degradation processes (chemical, thermal, and biological), they have become some of the most substantial pollutants of the present. The ubiquitous nature of PFAS stems from their use in a wide variety of industrial and consumer products for over several decades. Common applications include firefighting foams, nonstick cookware, cosmetics, paints, apparel, and automotive lubricants. Because of their widespread use and still rather limited restrictions across the globe, the exposure of PFAS to humans and animals is becoming increasingly prominent across the globe. Consequently, increasing numbers of toxicological studies have shown a strong correlation between PFAS exposure and health impacts, including autoimmune disorders, thyroid dysfunction, renal disease, carcinogenesis, and cardiovascular disease. Importantly, the U.S. Environmental Protection Agency (EPA) has listed six PFAS compounds on their Third Unmonitored Contaminant Rule as of 2021 . Thus, legacy PFAS molecules included on the EPA list, such as PFOS and PFOA, have been phased out of production in the U.S. since 2002 and 2015, respectively .…”
Section: Introductionmentioning
confidence: 99%
“…Over the last decade, increasing attention has been given to understand the detrimental impacts of per- and polyfluoroalkyl substances (PFAS) on the environment and on human and animal health. PFAS are prevalent in natural settings, and, paired with their extreme stability against various degradation processes (chemical, thermal, and biological), they have become some of the most substantial pollutants of the present. The ubiquitous nature of PFAS stems from their use in a wide variety of industrial and consumer products for over several decades. Common applications include firefighting foams, nonstick cookware, cosmetics, paints, apparel, and automotive lubricants. Because of their widespread use and still rather limited restrictions across the globe, the exposure of PFAS to humans and animals is becoming increasingly prominent across the globe. Consequently, increasing numbers of toxicological studies have shown a strong correlation between PFAS exposure and health impacts, including autoimmune disorders, thyroid dysfunction, renal disease, carcinogenesis, and cardiovascular disease. Importantly, the U.S. Environmental Protection Agency (EPA) has listed six PFAS compounds on their Third Unmonitored Contaminant Rule as of 2021 . Thus, legacy PFAS molecules included on the EPA list, such as PFOS and PFOA, have been phased out of production in the U.S. since 2002 and 2015, respectively .…”
Section: Introductionmentioning
confidence: 99%